Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry

British Journal of Surgery

Volumn 101, Issue 7, 2014, Pages 768-774

  Desai, R ^a   Collett, D ^a   Watson, C J E ^b   Johnson, P ^c   Evans, T ^d   Neuberger, J ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; DONOR; HEART TRANSPLANTATION; HUMAN; KIDNEY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MIDDLE AGED; MORTALITY; PANCREAS TRANSPLANTATION; PRACTICE GUIDELINE; REGISTER; RISK FACTOR; STANDARD; STATISTICS; SURVIVAL; TRANSPLANTATION; TUMOR SEEDING; UNITED KINGDOM;

ADULT; CENTRAL NERVOUS SYSTEM NEOPLASMS; ENGLAND; GUIDELINES AS TOPIC; HEART TRANSPLANTATION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MIDDLE AGED; NEOPLASM SEEDING; PANCREAS TRANSPLANTATION; REGISTRIES; RISK FACTORS; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 84900490615     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9460     Document Type: Article

References (30)

1. Kauffman HM, McBride MA, Cherikh WS, Spain PC, Delmonico FL,. Transplant tumor registry: donor related malignancies. Transplantation 2002; 74: 358-362.
2. Desai R, Collett D, Watson CJ, Johnson P, Evans T, Neuberger J,. Cancer transmission from organ donors-unavoidable but low risk. Transplantation 2012; 94: 1200-1207.
3. NHS Blood and Transplant. Transplant Activity in the UK: Archive Activity Reports 2001-2010. http://www.organdonation.nhs.uk/ukt/statistics/transplant- activity-report/archive-activity-reports/archive-activity-reports.asp [accessed 1 May 2013].
4. BBC News. Inquiry Launched as Transplant Patients Contract Cancer; 22 March 2011. http://www.bbc.co.uk/news/health-12792136 [accessed 1 May 2013].
5. MailOnline. 'Cancer' Liver Transplant Killed Husband. http://www.dailymail.co.uk/health/article-207838/Cancer-liver-transplant-killed- husband.html [accessed 1 May 2013].
6. CNN.com/health. Soldier Dies after Receiving Smoker's Lungs in Transplant; 12 October 2009. http://articles.cnn.com/2009-10-12/health/soldier. lung.cancer.transplant-1-donor-lungs-lung-transplants-new-lungs?-s=PM:HEALTH [accessed 1 May 2013].
7. Council of Europe, European Directorate for the Quality of Medicines and HealthCare. Guide to the Safety and Quality Assurance for the Transplantation of Organs, Tissues and Cells (4th edn); 2010. http://www.edqm.eu/en/Blood- Transfusion-Organ-Transplantation-Guides-1131.html [accessed 1 May 2013].
8. Nalesnik MA, Woodle ES, Dimaio JM, Vasudev B, Teperman LW, Covington S, et al. Donor transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant 2011; 11: 1140-1147.
9. NHS Blood and Transplant. Potential Donor Audit: Summary Report for the 12 Month Period 01 April 2011-31 March 2012. http://www.organdonation.nhs.uk/ statistics/potential-donor-audit [accessed 1 May 2013].
10. NHS Blood and Transplant. Organ Donation and Transplantation: Activity Report 2011/12. www.organdonation.nhs.uk/statistics/transplant-activity-report/ archive-activity-reports/ [accessed 1 May 2013].
11. Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW,. Deceased donor with a past history of malignancy: an Organ Procurement and Transplantation Network/United Network of Organ Sharing update. Transplantation 2007; 84: 272-274.
12. Watson CJE, Roberts R, Wright KA, Greenberg DC, Rous BA, Brown CH, et al. How safe is it to transplant organs from deceased donors with primary intracranial malignancy? An analysis of UK registry data. Am J Transplant 2010; 10: 1-8.
13. Warrens AN, Birch R, Collett D, Daraktchiev M, Dark JH, Galea G, et al.; Advisory Committee on the Safety of Blood, Tissues and Organs, UK. Advising potential recipients on the use of organs from donors with primary central nervous system tumours. Transplantation 2012; 93: 348-353.
14. Crowley NJ, Seigler HF,. Late recurrence of malignant melanoma: analysis of 168 patients. Ann Surg 1990; 212: 173-177.
15. Tsao H, Cosimi AB, Sober AJ,. Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer 1997; 79: 2361-2370.
16. Dicker TJ, Kavanagh GM, Herd RM, Ahmad T, McLaren KM, Chetty U, et al. A rational approach to melanoma follow-up in patients with primary cutaneous melanoma. Scottish Melanoma Group. Br J Dermatol 1999; 140: 249-254.
17. Penn I., Malignant melanoma in organ allograft recipients. Transplantation 1996; 61: 274-278.
18. Carli P, De Giorgi V, Palli D, Maurichi A, Mulas P, Orlandi C, et al. Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study. Dermatol Surg 2004; 30: 1371-1375.
19. Bosco JL, Lash TL, Prout MN, Buist DS, Geiger AM, Haque R, et al.; BOW Investigators. Breast cancer recurrence in older women five to ten years after diagnosis. Cancer Epidemiol Biomarkers Prev 2009; 18: 2979-2983.
20. Brewster AM, Hortobagyi GN, Broglio KR, Kau SW, Santa-Maria CA, Arun B, et al. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst 2008; 100: 1179-1183.
21. Lousberg L, Somia J, Collignon J, Gilles C, Jerusalem G,. [ Late relapse of breast cancer after adjuvant chemotherapy.] Rev Med Liege 2011; 66: 306-310.
22. Cheng L, Swartz MD, Zhao H, Kapadia AS, Lai D, Rowan PJ, et al. Hazard of recurrence among women after primary breast cancer treatment-a 10-year follow-up using data from SEER-Medicare. Cancer Epidemiol Biomarkers Prev 2012; 21: 800-809.
23. Cancer Research UK. Ovarian Cancer Survival Statistics. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/ovary/survival/ [accessed 1 May 2013].
24. Gadducci A, Tana R, Teti G, Fanucchi A, Pasqualetti F, Cionini L, et al. Brain recurrences in patients with ovarian cancer: report of 12 cases and review of the literature. Anticancer Res 2007; 27: 4403-4410.
25. Bellati F, Napoletano C, Nuti M, Benedetti Panici P,. Death from metastatic donor-derived ovarian cancer in a male kidney transplant recipient. Am J Transpl 2009; 9: 1253.
26. Cho YB, Chun HK, Yun HR, Lee WS, Yun SH, Lee WY, et al. Clinical and pathologic evaluation of patients with recurrence of colorectal cancer five or more years after curative resection. Dis Col Rectum 2007; 50: 1204-1210.
27. Buell JF, Beebe TM, Trofe J, Gross TG, Alloway RR, Hanaway MJ, et al. Donor transmitted malignancies. Ann Transplant 2004; 9: 53-56.
28. Birkeland SA, Storm HH,. Risk for tumour and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation 2002; 74: 1409-1413.
29. NHS Blood and Transplant; British Transplantation Society. Guidelines for Consent for Solid Organ Transplantation in Adults; 2011. http://www.nhsbt.nhs. uk/pdf/guidelines-for-consent.pdf [accessed 1 May 2013].
30. Kaye JA, Derby LE, del Mar Melero-Montes M, Quinn M, Jick H,. The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer 2000; 83: 1556-1558.